Le Lézard
Classified in: Health
Subjects: PER, SHM

Medical Facilities Corporation Announces Results of 2024 Annual Meeting of Shareholders


TORONTO, May 9, 2024 /CNW/ - Medical Facilities Corporation (TSX: DR) ("Medical Facilities", "MFC" or the "Corporation") announced that the nominees listed in the management information circular for the 2024 Annual Meeting of Shareholders (the "Meeting") held on May 9, 2024 via online webcast were elected as directors of the Corporation.

Detailed results of the votes by proxy and ballot for the election of directors are set out below.

Nominee

Votes
For

% of Votes
For

Votes
Withheld

% of Votes
Withheld

Yanick Blanchard

6,600,999

99.32 %

45,420

0.68 %

Erin S. Enright

6,606,241

99.40 %

40,178

0.60 %

Michael V. Gisser

6,283,088

94.53 %

363,331

5.47 %

Jason P. Redman

6,595,290

99.23 %

51,129

0.77 %

Reza Shahim

6,586,898

99.10 %

59,521

0.90 %

Adina G. Storch

6,597,863

99.27 %

48,556

0.73 %

At the Meeting, the shareholders of the Corporation also approved the appointment of Raymond Chabot Grant Thornton LLP as auditors of the Corporation and authorized the board of directors of the Corporation to fix their remuneration, with 99.63% of the votes in favour.

About Medical Facilities Corporation

Medical Facilities, in partnership with physicians, owns a portfolio of highly rated, high-quality surgical facilities in the United States. MFC's ownership includes controlling interest in four specialty surgical hospitals located in Arkansas, Oklahoma, and South Dakota, and an ambulatory surgery center ("ASC") located in California. The specialty surgical hospitals perform scheduled surgical, imaging, diagnostic and other procedures, including primary and urgent care, and derive their revenue from the fees charged for the use of their facilities. The ASC specializes in outpatient surgical procedures, with patient stays of less than 24 hours. For more information, please visit www.medicalfacilitiescorp.ca.

Caution concerning forward-looking statements

Statements made in this news release, other than those concerning historical financial information, may be forward-looking and therefore subject to various risks and uncertainties.  Some forward-looking statements may be identified by words like "may", "will", "anticipate", "estimate", "expect", "intend", or "continue" or the negative thereof or similar variations. Certain material factors or assumptions are applied in making forward-looking statements and actual results may differ materially from those expressed or implied in such statements. Factors that could cause results to vary include those identified in Medical Facilities' filings with Canadian securities regulatory authorities such as legislative or regulatory developments, intensifying competition, technological change and general economic conditions. All forward-looking statements presented herein should be considered in conjunction with such filings. Medical Facilities does not undertake to update any forward-looking statements; such statements speak only as of the date made.

SOURCE Medical Facilities Corporation


These press releases may also interest you

at 07:40
The "Global Enzyme Contract Manufacturing Market (2024 Edition): Analysis By Source (Plant, Animal, Microbe), By Application, By End-Use, By Region: Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's offering....

at 07:30
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, encourages its eligible stockholders to participate in...

at 07:30
Shoulder Innovations, a leader in the shoulder replacement implant market, is proud to announce the launch of its latest product: the InSettm 95 Humeral Stem. This product is designed to enhance surgical outcomes and improve patient recovery for...

at 07:15
mBIOTA Labs, a medical food company revolutionizing oral nutrition through their proprietary palatable elemental diet, mBIOTA Elementaltm, today announced the initial study results of their first prospective clinical trial assessing the efficacy of...

at 07:15
Epicutis®, a professional, medical-grade luxury skincare line by Signum Biosciences, is thrilled to announce its partnership with the Four Seasons Hotel Toronto along with new Epicutis® Lipid Recovery Mask for Eyes, developed in collaboration with...

at 07:05
Beaconcure Inc., a leader in AI-enabled clinical data validation and automation, announces a strategic partnership with Phastar Inc., a global specialist biometrics contract research organization (CRO), to enhance clinical review processes in...



News published on and distributed by: